nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP1A2—chronic obstructive pulmonary disease	0.268	0.542	CbGaD
Iloperidone—HTR2A—chronic obstructive pulmonary disease	0.226	0.458	CbGaD
Iloperidone—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0515	0.205	CbGbCtD
Iloperidone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0298	0.119	CbGbCtD
Iloperidone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0289	0.115	CbGbCtD
Iloperidone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0289	0.115	CbGbCtD
Iloperidone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0257	0.103	CbGbCtD
Iloperidone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0242	0.0966	CbGbCtD
Iloperidone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0164	0.0652	CbGbCtD
Iloperidone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0156	0.0622	CbGbCtD
Iloperidone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0139	0.0555	CbGbCtD
Iloperidone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00816	0.0326	CbGbCtD
Iloperidone—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00792	0.239	CbGeAlD
Iloperidone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0077	0.0307	CbGbCtD
Iloperidone—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00461	0.139	CbGeAlD
Iloperidone—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00288	0.0867	CbGeAlD
Iloperidone—Gefitinib—ERBB3—chronic obstructive pulmonary disease	0.00174	0.307	CrCbGaD
Iloperidone—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000857	0.0258	CbGeAlD
Iloperidone—Gefitinib—EGFR—chronic obstructive pulmonary disease	0.000782	0.138	CrCbGaD
Iloperidone—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000776	0.0234	CbGeAlD
Iloperidone—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.000747	0.0225	CbGeAlD
Iloperidone—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000733	0.0221	CbGeAlD
Iloperidone—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000731	0.022	CbGeAlD
Iloperidone—Paliperidone—HTR2A—chronic obstructive pulmonary disease	0.000723	0.127	CrCbGaD
Iloperidone—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000683	0.0206	CbGeAlD
Iloperidone—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.000671	0.0202	CbGeAlD
Iloperidone—Cisapride—CYP1A2—chronic obstructive pulmonary disease	0.00065	0.114	CrCbGaD
Iloperidone—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000625	0.0188	CbGeAlD
Iloperidone—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000619	0.0186	CbGeAlD
Iloperidone—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000597	0.018	CbGeAlD
Iloperidone—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000587	0.0177	CbGeAlD
Iloperidone—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000579	0.0175	CbGeAlD
Iloperidone—HTR7—trachea—chronic obstructive pulmonary disease	0.000573	0.0173	CbGeAlD
Iloperidone—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000557	0.0168	CbGeAlD
Iloperidone—Cisapride—HTR2A—chronic obstructive pulmonary disease	0.000548	0.0964	CrCbGaD
Iloperidone—Risperidone—HTR2A—chronic obstructive pulmonary disease	0.000539	0.0949	CrCbGaD
Iloperidone—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000527	0.0159	CbGeAlD
Iloperidone—HRH1—connective tissue—chronic obstructive pulmonary disease	0.00051	0.0154	CbGeAlD
Iloperidone—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000506	0.00378	CcSEcCtD
Iloperidone—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000501	0.0151	CbGeAlD
Iloperidone—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00369	CcSEcCtD
Iloperidone—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00367	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000487	0.00363	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.00363	CcSEcCtD
Iloperidone—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000485	0.00362	CcSEcCtD
Iloperidone—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000484	0.0146	CbGeAlD
Iloperidone—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000483	0.00361	CcSEcCtD
Iloperidone—SIGMAR1—lung—chronic obstructive pulmonary disease	0.000482	0.0145	CbGeAlD
Iloperidone—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00356	CcSEcCtD
Iloperidone—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000471	0.00352	CcSEcCtD
Iloperidone—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000468	0.0141	CbGeAlD
Iloperidone—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000468	0.00349	CcSEcCtD
Iloperidone—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000466	0.0141	CbGeAlD
Iloperidone—Delusion—Prednisone—chronic obstructive pulmonary disease	0.000464	0.00346	CcSEcCtD
Iloperidone—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000464	0.00346	CcSEcCtD
Iloperidone—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00345	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00343	CcSEcCtD
Iloperidone—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000455	0.0034	CcSEcCtD
Iloperidone—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00339	CcSEcCtD
Iloperidone—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00339	CcSEcCtD
Iloperidone—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000452	0.00337	CcSEcCtD
Iloperidone—Mania—Prednisone—chronic obstructive pulmonary disease	0.000452	0.00337	CcSEcCtD
Iloperidone—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000449	0.00335	CcSEcCtD
Iloperidone—Gefitinib—CYP1A1—chronic obstructive pulmonary disease	0.000448	0.0787	CrCbGaD
Iloperidone—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00332	CcSEcCtD
Iloperidone—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000441	0.00329	CcSEcCtD
Iloperidone—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000433	0.00323	CcSEcCtD
Iloperidone—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000431	0.00322	CcSEcCtD
Iloperidone—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.00321	CcSEcCtD
Iloperidone—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.0032	CcSEcCtD
Iloperidone—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.0032	CcSEcCtD
Iloperidone—HRH1—trachea—chronic obstructive pulmonary disease	0.000428	0.0129	CbGeAlD
Iloperidone—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00318	CcSEcCtD
Iloperidone—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000426	0.0128	CbGeAlD
Iloperidone—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.00316	CcSEcCtD
Iloperidone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000421	0.00314	CcSEcCtD
Iloperidone—ADRA2A—trachea—chronic obstructive pulmonary disease	0.00042	0.0127	CbGeAlD
Iloperidone—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.0031	CcSEcCtD
Iloperidone—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00309	CcSEcCtD
Iloperidone—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00309	CcSEcCtD
Iloperidone—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.00307	CcSEcCtD
Iloperidone—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000412	0.00307	CcSEcCtD
Iloperidone—HTR7—lung—chronic obstructive pulmonary disease	0.000412	0.0124	CbGeAlD
Iloperidone—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00307	CcSEcCtD
Iloperidone—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00307	CcSEcCtD
Iloperidone—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00303	CcSEcCtD
Iloperidone—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00301	CcSEcCtD
Iloperidone—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000402	0.003	CcSEcCtD
Iloperidone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000401	0.003	CcSEcCtD
Iloperidone—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00298	CcSEcCtD
Iloperidone—Endocrine disorder—Prednisone—chronic obstructive pulmonary disease	0.000396	0.00296	CcSEcCtD
Iloperidone—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00292	CcSEcCtD
Iloperidone—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000389	0.0117	CbGeAlD
Iloperidone—DRD2—lung—chronic obstructive pulmonary disease	0.000389	0.0117	CbGeAlD
Iloperidone—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000389	0.0029	CcSEcCtD
Iloperidone—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.0029	CcSEcCtD
Iloperidone—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.0029	CcSEcCtD
Iloperidone—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.0029	CcSEcCtD
Iloperidone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000388	0.0029	CcSEcCtD
Iloperidone—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.0029	CcSEcCtD
Iloperidone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.00287	CcSEcCtD
Iloperidone—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.00287	CcSEcCtD
Iloperidone—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000384	0.00286	CcSEcCtD
Iloperidone—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000382	0.00285	CcSEcCtD
Iloperidone—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000382	0.00285	CcSEcCtD
Iloperidone—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00284	CcSEcCtD
Iloperidone—ADRA2C—lung—chronic obstructive pulmonary disease	0.000379	0.0114	CbGeAlD
Iloperidone—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000378	0.00282	CcSEcCtD
Iloperidone—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000378	0.00282	CcSEcCtD
Iloperidone—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.00281	CcSEcCtD
Iloperidone—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00279	CcSEcCtD
Iloperidone—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00279	CcSEcCtD
Iloperidone—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000374	0.00279	CcSEcCtD
Iloperidone—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00037	0.00276	CcSEcCtD
Iloperidone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00037	0.00276	CcSEcCtD
Iloperidone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00037	0.00276	CcSEcCtD
Iloperidone—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00275	CcSEcCtD
Iloperidone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00275	CcSEcCtD
Iloperidone—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00274	CcSEcCtD
Iloperidone—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00274	CcSEcCtD
Iloperidone—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00274	CcSEcCtD
Iloperidone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00274	CcSEcCtD
Iloperidone—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.00273	CcSEcCtD
Iloperidone—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00272	CcSEcCtD
Iloperidone—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00272	CcSEcCtD
Iloperidone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000362	0.0027	CcSEcCtD
Iloperidone—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00036	0.00269	CcSEcCtD
Iloperidone—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00268	CcSEcCtD
Iloperidone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00268	CcSEcCtD
Iloperidone—HTR2A—trachea—chronic obstructive pulmonary disease	0.000357	0.0108	CbGeAlD
Iloperidone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00266	CcSEcCtD
Iloperidone—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00264	CcSEcCtD
Iloperidone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00262	CcSEcCtD
Iloperidone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00262	CcSEcCtD
Iloperidone—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00261	CcSEcCtD
Iloperidone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000349	0.0026	CcSEcCtD
Iloperidone—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00259	CcSEcCtD
Iloperidone—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00258	CcSEcCtD
Iloperidone—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00257	CcSEcCtD
Iloperidone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00256	CcSEcCtD
Iloperidone—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00255	CcSEcCtD
Iloperidone—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00255	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000336	0.00251	CcSEcCtD
Iloperidone—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.0025	CcSEcCtD
Iloperidone—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000335	0.0025	CcSEcCtD
Iloperidone—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000335	0.0025	CcSEcCtD
Iloperidone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000331	0.00247	CcSEcCtD
Iloperidone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00247	CcSEcCtD
Iloperidone—CYP1A2—lung—chronic obstructive pulmonary disease	0.000328	0.0099	CbGeAlD
Iloperidone—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00245	CcSEcCtD
Iloperidone—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.00241	CcSEcCtD
Iloperidone—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00241	CcSEcCtD
Iloperidone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00241	CcSEcCtD
Iloperidone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00241	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.00238	CcSEcCtD
Iloperidone—CYP3A5—lung—chronic obstructive pulmonary disease	0.000317	0.00955	CbGeAlD
Iloperidone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00236	CcSEcCtD
Iloperidone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00236	CcSEcCtD
Iloperidone—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00233	CcSEcCtD
Iloperidone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Iloperidone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Iloperidone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Iloperidone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Iloperidone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Iloperidone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00231	CcSEcCtD
Iloperidone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00231	CcSEcCtD
Iloperidone—HRH1—lung—chronic obstructive pulmonary disease	0.000308	0.00927	CbGeAlD
Iloperidone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Iloperidone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Iloperidone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Iloperidone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Iloperidone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Iloperidone—ADRA2A—lung—chronic obstructive pulmonary disease	0.000302	0.0091	CbGeAlD
Iloperidone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00222	CcSEcCtD
Iloperidone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00222	CcSEcCtD
Iloperidone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00221	CcSEcCtD
Iloperidone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00221	CcSEcCtD
Iloperidone—CYP2E1—lung—chronic obstructive pulmonary disease	0.000296	0.00891	CbGeAlD
Iloperidone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00219	CcSEcCtD
Iloperidone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00219	CcSEcCtD
Iloperidone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00218	CcSEcCtD
Iloperidone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00218	CcSEcCtD
Iloperidone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00218	CcSEcCtD
Iloperidone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00217	CcSEcCtD
Iloperidone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00217	CcSEcCtD
Iloperidone—Infection—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00216	CcSEcCtD
Iloperidone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00214	CcSEcCtD
Iloperidone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00213	CcSEcCtD
Iloperidone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.0021	CcSEcCtD
Iloperidone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00208	CcSEcCtD
Iloperidone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00208	CcSEcCtD
Iloperidone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00208	CcSEcCtD
Iloperidone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00206	CcSEcCtD
Iloperidone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00205	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00202	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00202	CcSEcCtD
Iloperidone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000268	0.002	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00198	CcSEcCtD
Iloperidone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00198	CcSEcCtD
Iloperidone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00198	CcSEcCtD
Iloperidone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00198	CcSEcCtD
Iloperidone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00198	CcSEcCtD
Iloperidone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00196	CcSEcCtD
Iloperidone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00195	CcSEcCtD
Iloperidone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00194	CcSEcCtD
Iloperidone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00193	CcSEcCtD
Iloperidone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00193	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00192	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00192	CcSEcCtD
Iloperidone—HTR2A—lung—chronic obstructive pulmonary disease	0.000257	0.00774	CbGeAlD
Iloperidone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00192	CcSEcCtD
Iloperidone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00192	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00191	CcSEcCtD
Iloperidone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00189	CcSEcCtD
Iloperidone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00189	CcSEcCtD
Iloperidone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00188	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00188	CcSEcCtD
Iloperidone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00188	CcSEcCtD
Iloperidone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00187	CcSEcCtD
Iloperidone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00187	CcSEcCtD
Iloperidone—Gefitinib—ALB—chronic obstructive pulmonary disease	0.000249	0.0438	CrCbGaD
Iloperidone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000247	0.00184	CcSEcCtD
Iloperidone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000246	0.00184	CcSEcCtD
Iloperidone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00183	CcSEcCtD
Iloperidone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00183	CcSEcCtD
Iloperidone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00183	CcSEcCtD
Iloperidone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00182	CcSEcCtD
Iloperidone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000244	0.00182	CcSEcCtD
Iloperidone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00182	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00181	CcSEcCtD
Iloperidone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00181	CcSEcCtD
Iloperidone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00176	CcSEcCtD
Iloperidone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00176	CcSEcCtD
Iloperidone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00175	CcSEcCtD
Iloperidone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00174	CcSEcCtD
Iloperidone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000233	0.00174	CcSEcCtD
Iloperidone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00173	CcSEcCtD
Iloperidone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000232	0.00173	CcSEcCtD
Iloperidone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00173	CcSEcCtD
Iloperidone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00172	CcSEcCtD
Iloperidone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00169	CcSEcCtD
Iloperidone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00166	CcSEcCtD
Iloperidone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.00164	CcSEcCtD
Iloperidone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00162	CcSEcCtD
Iloperidone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00159	CcSEcCtD
Iloperidone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00159	CcSEcCtD
Iloperidone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00156	CcSEcCtD
Iloperidone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00152	CcSEcCtD
Iloperidone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00152	CcSEcCtD
Iloperidone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00151	CcSEcCtD
Iloperidone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00151	CcSEcCtD
Iloperidone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00149	CcSEcCtD
Iloperidone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00147	CcSEcCtD
Iloperidone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00147	CcSEcCtD
Iloperidone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00144	CcSEcCtD
Iloperidone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00144	CcSEcCtD
Iloperidone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00142	CcSEcCtD
Iloperidone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000188	0.0014	CcSEcCtD
Iloperidone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.0014	CcSEcCtD
Iloperidone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.0014	CcSEcCtD
Iloperidone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000188	0.0014	CcSEcCtD
Iloperidone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000188	0.0014	CcSEcCtD
Iloperidone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00139	CcSEcCtD
Iloperidone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00139	CcSEcCtD
Iloperidone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00139	CcSEcCtD
Iloperidone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00137	CcSEcCtD
Iloperidone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00137	CcSEcCtD
Iloperidone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00132	CcSEcCtD
Iloperidone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00132	CcSEcCtD
Iloperidone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00132	CcSEcCtD
Iloperidone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00132	CcSEcCtD
Iloperidone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00132	CcSEcCtD
Iloperidone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00129	CcSEcCtD
Iloperidone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00125	CcSEcCtD
Iloperidone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00121	CcSEcCtD
Iloperidone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.0012	CcSEcCtD
Iloperidone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00117	CcSEcCtD
Iloperidone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00115	CcSEcCtD
Iloperidone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00112	CcSEcCtD
Iloperidone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.0011	CcSEcCtD
Iloperidone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.00108	CcSEcCtD
Iloperidone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00108	CcSEcCtD
Iloperidone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00107	CcSEcCtD
Iloperidone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00101	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000992	CcSEcCtD
Iloperidone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00099	CcSEcCtD
Iloperidone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000985	CcSEcCtD
Iloperidone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000963	CcSEcCtD
Iloperidone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000912	CcSEcCtD
Iloperidone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000912	CcSEcCtD
Iloperidone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000875	CcSEcCtD
Iloperidone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000869	CcSEcCtD
Iloperidone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000858	CcSEcCtD
Iloperidone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000854	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000797	CcSEcCtD
Iloperidone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000796	CcSEcCtD
Iloperidone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000785	CcSEcCtD
Iloperidone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000759	CcSEcCtD
Iloperidone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000758	CcSEcCtD
Iloperidone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000754	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000721	CcSEcCtD
Iloperidone—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.58e-05	0.000715	CcSEcCtD
Iloperidone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.26e-05	0.000691	CcSEcCtD
Iloperidone—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000627	CcSEcCtD
Iloperidone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.02e-05	0.000598	CcSEcCtD
Iloperidone—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000578	CcSEcCtD
Iloperidone—Rash—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000551	CcSEcCtD
Iloperidone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000551	CcSEcCtD
Iloperidone—Nausea—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000519	CcSEcCtD
Iloperidone—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.72e-06	0.000118	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.71e-06	0.000118	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.64e-06	0.000117	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.59e-06	0.000116	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.58e-06	0.000116	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.54e-06	0.000116	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.53e-06	0.000116	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.51e-06	0.000115	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.4e-06	0.000114	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.39e-06	0.000114	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.38e-06	0.000114	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.34e-06	0.000113	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.33e-06	0.000113	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.28e-06	0.000113	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.27e-06	0.000113	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.26e-06	0.000112	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.2e-06	0.000112	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.09e-06	0.00011	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.08e-06	0.00011	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.04e-06	0.00011	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.03e-06	0.00011	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.03e-06	0.00011	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.01e-06	0.000109	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.98e-06	0.000109	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.93e-06	0.000108	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.93e-06	0.000108	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.91e-06	0.000108	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.87e-06	0.000108	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.87e-06	0.000108	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.85e-06	0.000107	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.85e-06	0.000107	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.84e-06	0.000107	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.8e-06	0.000107	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.78e-06	0.000107	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.76e-06	0.000106	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.75e-06	0.000106	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.74e-06	0.000106	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.69e-06	0.000105	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.68e-06	0.000105	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.46e-06	0.000103	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.45e-06	0.000103	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.44e-06	0.000102	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.38e-06	0.000102	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.35e-06	0.000101	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.3e-06	0.000101	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.3e-06	0.000101	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.28e-06	0.000101	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.27e-06	0.0001	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.25e-06	0.0001	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.19e-06	9.95e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.17e-06	9.92e-05	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.13e-06	9.87e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.11e-06	9.85e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.11e-06	9.84e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.1e-06	9.83e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.08e-06	9.81e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.08e-06	9.81e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.07e-06	9.79e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.06e-06	9.79e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.04e-06	9.76e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.98e-06	9.69e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.94e-06	9.64e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	7.89e-06	9.58e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.89e-06	9.58e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.88e-06	9.57e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.88e-06	9.56e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	7.79e-06	9.46e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.74e-06	9.4e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.62e-06	9.25e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.62e-06	9.25e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.6e-06	9.22e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	7.57e-06	9.19e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.52e-06	9.13e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.49e-06	9.1e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.49e-06	9.09e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.46e-06	9.05e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.45e-06	9.05e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.44e-06	9.03e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.38e-06	8.96e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.33e-06	8.9e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.33e-06	8.9e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.27e-06	8.83e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	7.24e-06	8.79e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.21e-06	8.76e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.2e-06	8.74e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.18e-06	8.71e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.17e-06	8.7e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.13e-06	8.65e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.12e-06	8.64e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.07e-06	8.59e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.06e-06	8.57e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.06e-06	8.57e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.86e-06	8.33e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.83e-06	8.29e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.81e-06	8.27e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.78e-06	8.23e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.77e-06	8.22e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.76e-06	8.21e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.73e-06	8.17e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.67e-06	8.1e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.64e-06	8.06e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.56e-06	7.97e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.55e-06	7.95e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.52e-06	7.91e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.48e-06	7.87e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.45e-06	7.83e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.38e-06	7.74e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.37e-06	7.73e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.34e-06	7.7e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.31e-06	7.66e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.25e-06	7.59e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.22e-06	7.55e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.21e-06	7.55e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	6.15e-06	7.46e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.13e-06	7.45e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.09e-06	7.39e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.08e-06	7.38e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.05e-06	7.35e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.05e-06	7.35e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.04e-06	7.33e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.03e-06	7.32e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.93e-06	7.2e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.92e-06	7.18e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.89e-06	7.15e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.88e-06	7.14e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.84e-06	7.08e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.82e-06	7.07e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.81e-06	7.05e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.76e-06	6.99e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.75e-06	6.99e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.75e-06	6.98e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.73e-06	6.96e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.66e-06	6.87e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.65e-06	6.86e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.65e-06	6.86e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	5.64e-06	6.85e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.63e-06	6.84e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.59e-06	6.78e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.58e-06	6.78e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.55e-06	6.74e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.54e-06	6.73e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.54e-06	6.73e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.52e-06	6.7e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.49e-06	6.67e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.48e-06	6.65e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.47e-06	6.64e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.44e-06	6.6e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.4e-06	6.56e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.4e-06	6.55e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.39e-06	6.55e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.39e-06	6.55e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.39e-06	6.54e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.37e-06	6.52e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.34e-06	6.49e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.3e-06	6.44e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.29e-06	6.42e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.28e-06	6.4e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.26e-06	6.39e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.25e-06	6.37e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.24e-06	6.36e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.24e-06	6.36e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.17e-06	6.28e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.15e-06	6.25e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.1e-06	6.2e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.02e-06	6.09e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.99e-06	6.06e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.99e-06	6.06e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.92e-06	5.97e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.87e-06	5.91e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.86e-06	5.89e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.81e-06	5.84e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.79e-06	5.82e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.78e-06	5.81e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.75e-06	5.76e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.72e-06	5.72e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.69e-06	5.7e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.65e-06	5.65e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.63e-06	5.62e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.6e-06	5.58e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.59e-06	5.58e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.56e-06	5.54e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.56e-06	5.53e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.55e-06	5.52e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.51e-06	5.47e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.48e-06	5.44e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.46e-06	5.42e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.42e-06	5.37e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.41e-06	5.35e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.4e-06	5.34e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.36e-06	5.29e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.36e-06	5.29e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.36e-06	5.29e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.33e-06	5.26e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.33e-06	5.25e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.24e-06	5.15e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.21e-06	5.11e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.21e-06	5.11e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.18e-06	5.07e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.15e-06	5.03e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.14e-06	5.02e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.11e-06	5e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.06e-06	4.93e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.05e-06	4.92e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.03e-06	4.9e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.03e-06	4.89e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4e-06	4.86e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4e-06	4.86e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.96e-06	4.81e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.96e-06	4.8e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.94e-06	4.79e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.92e-06	4.76e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.91e-06	4.74e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.89e-06	4.73e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.88e-06	4.72e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.85e-06	4.68e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.83e-06	4.65e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.81e-06	4.63e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.63e-06	4.41e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.62e-06	4.4e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.58e-06	4.34e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.57e-06	4.34e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.56e-06	4.33e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.56e-06	4.32e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.54e-06	4.3e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.5e-06	4.25e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.5e-06	4.25e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.5e-06	4.24e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.43e-06	4.16e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.4e-06	4.13e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.39e-06	4.12e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.39e-06	4.11e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.29e-06	4e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.25e-06	3.95e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.25e-06	3.94e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.19e-06	3.87e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.12e-06	3.78e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.1e-06	3.76e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.02e-06	3.66e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.99e-06	3.63e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.94e-06	3.57e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.93e-06	3.56e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.88e-06	3.5e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.74e-06	3.32e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.69e-06	3.27e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.69e-06	3.26e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.68e-06	3.25e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.64e-06	3.2e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.62e-06	3.18e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.5e-06	3.04e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.45e-06	2.97e-05	CbGpPWpGaD
